Decades of research in drug targeting using gastroretentive drug delivery systems for antihypertensive therapy
ABSTRACT The limitations in absorption of drugs with narrow absorption window, or those unstable in the intestinal pH or those exhibiting low solubility at high pH are primary candidates for gastroretentive drug delivery systems (GRDDS). The delivery system has been widely explored for its commercial potential for a wide variety of therapeutic agents. GRDDS offer clinical therapeutics for acute and chronic management. Hypertension is a chronic disease that requires long term treatment and its management by patient compliant dosage forms would be clinically useful. Antihypertensives belonging to different classes have proved good candidates for the formulation of GRDDS. The review aims to discuss various GRDDS researched for antihypertensive drugs to increase the gastric residing time, bioavailability, henceforth to reduce the dose of the drug, dosing frequency and increase patient compliance. It also explores various marketed products and the patents filed/granted for GRRDS of antihypertensives. The GRDDS investigated include effervescent and non-effervescent floating drug delivery systems, swelling and expanding systems and bio/mucoadhesive systems. Many other systems that provided research platforms include high density systems, raft forming systems and osmotic delivery systems. In clinical context, wherein combination of antihypertensives is indicated, dual release delivery systems may also be explored.
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Digital revista |
| Language: | English |
| Published: |
Universidade de São Paulo, Faculdade de Ciências Farmacêuticas
2017
|
| Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502017000300401 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
oai:scielo:S1984-82502017000300401 |
|---|---|
| record_format |
ojs |
| spelling |
oai:scielo:S1984-825020170003004012018-02-02Decades of research in drug targeting using gastroretentive drug delivery systems for antihypertensive therapyPorwal,AmitDwivedi,HarinathPathak,Kamla Antihypertensive drugs Gastroretention delivery systems/absorption Floating systems Expanding and swelling systems Bio/mucoadhesive systems ABSTRACT The limitations in absorption of drugs with narrow absorption window, or those unstable in the intestinal pH or those exhibiting low solubility at high pH are primary candidates for gastroretentive drug delivery systems (GRDDS). The delivery system has been widely explored for its commercial potential for a wide variety of therapeutic agents. GRDDS offer clinical therapeutics for acute and chronic management. Hypertension is a chronic disease that requires long term treatment and its management by patient compliant dosage forms would be clinically useful. Antihypertensives belonging to different classes have proved good candidates for the formulation of GRDDS. The review aims to discuss various GRDDS researched for antihypertensive drugs to increase the gastric residing time, bioavailability, henceforth to reduce the dose of the drug, dosing frequency and increase patient compliance. It also explores various marketed products and the patents filed/granted for GRRDS of antihypertensives. The GRDDS investigated include effervescent and non-effervescent floating drug delivery systems, swelling and expanding systems and bio/mucoadhesive systems. Many other systems that provided research platforms include high density systems, raft forming systems and osmotic delivery systems. In clinical context, wherein combination of antihypertensives is indicated, dual release delivery systems may also be explored.info:eu-repo/semantics/openAccessUniversidade de São Paulo, Faculdade de Ciências FarmacêuticasBrazilian Journal of Pharmaceutical Sciences v.53 n.3 20172017-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502017000300401en10.1590/s2175-97902017000300173 |
| institution |
SCIELO |
| collection |
OJS |
| country |
Brasil |
| countrycode |
BR |
| component |
Revista |
| access |
En linea |
| databasecode |
rev-scielo-br |
| tag |
revista |
| region |
America del Sur |
| libraryname |
SciELO |
| language |
English |
| format |
Digital |
| author |
Porwal,Amit Dwivedi,Harinath Pathak,Kamla |
| spellingShingle |
Porwal,Amit Dwivedi,Harinath Pathak,Kamla Decades of research in drug targeting using gastroretentive drug delivery systems for antihypertensive therapy |
| author_facet |
Porwal,Amit Dwivedi,Harinath Pathak,Kamla |
| author_sort |
Porwal,Amit |
| title |
Decades of research in drug targeting using gastroretentive drug delivery systems for antihypertensive therapy |
| title_short |
Decades of research in drug targeting using gastroretentive drug delivery systems for antihypertensive therapy |
| title_full |
Decades of research in drug targeting using gastroretentive drug delivery systems for antihypertensive therapy |
| title_fullStr |
Decades of research in drug targeting using gastroretentive drug delivery systems for antihypertensive therapy |
| title_full_unstemmed |
Decades of research in drug targeting using gastroretentive drug delivery systems for antihypertensive therapy |
| title_sort |
decades of research in drug targeting using gastroretentive drug delivery systems for antihypertensive therapy |
| description |
ABSTRACT The limitations in absorption of drugs with narrow absorption window, or those unstable in the intestinal pH or those exhibiting low solubility at high pH are primary candidates for gastroretentive drug delivery systems (GRDDS). The delivery system has been widely explored for its commercial potential for a wide variety of therapeutic agents. GRDDS offer clinical therapeutics for acute and chronic management. Hypertension is a chronic disease that requires long term treatment and its management by patient compliant dosage forms would be clinically useful. Antihypertensives belonging to different classes have proved good candidates for the formulation of GRDDS. The review aims to discuss various GRDDS researched for antihypertensive drugs to increase the gastric residing time, bioavailability, henceforth to reduce the dose of the drug, dosing frequency and increase patient compliance. It also explores various marketed products and the patents filed/granted for GRRDS of antihypertensives. The GRDDS investigated include effervescent and non-effervescent floating drug delivery systems, swelling and expanding systems and bio/mucoadhesive systems. Many other systems that provided research platforms include high density systems, raft forming systems and osmotic delivery systems. In clinical context, wherein combination of antihypertensives is indicated, dual release delivery systems may also be explored. |
| publisher |
Universidade de São Paulo, Faculdade de Ciências Farmacêuticas |
| publishDate |
2017 |
| url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502017000300401 |
| work_keys_str_mv |
AT porwalamit decadesofresearchindrugtargetingusinggastroretentivedrugdeliverysystemsforantihypertensivetherapy AT dwivediharinath decadesofresearchindrugtargetingusinggastroretentivedrugdeliverysystemsforantihypertensivetherapy AT pathakkamla decadesofresearchindrugtargetingusinggastroretentivedrugdeliverysystemsforantihypertensivetherapy |
| _version_ |
1756437818576470016 |